Ultra Nasdaq Biotechnology 2X ETF (BIB)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
50.11 -0.88 (-1.73%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 50.11 unch (unch) 16:15 ET
for Fri, Mar 28th, 2025
Results
download Want to compare other data? Select FieldsSymbol | BIB | BIS | IBB | ||
Company | Ultra Nasdaq Biotechnology 2X ETF | Ultrashort Nasdaq Biotechnology -2X ETF | Nasdaq Biotechnology Ishares ETF | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 50.00 | 17.77 | 131.42 | ||
High | 50.50 | 18.03 | 131.85 | ||
Low | 49.79 | 17.77 | 129.97 | ||
Last | 50.11 | 17.92 | 130.29 | ||
Change | -0.88 | +0.31 | -1.29 | ||
% Change | -1.73% | +1.77% | -0.98% | ||
Volume | 6,300 | 8,600 | 1,278,000 | ||
20-Day Average Volume | 6,475 | 10,710 | 1,099,225 | ||
Previous Close | 50.99 | 17.61 | 131.58 | ||
Industry | N/A | N/A | Finance - Investment Funds | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 53.05 | 17.14 | 134.12 | ||
20-Day Raw Stochastic | 5.55% | 93.43% | 3.85% | ||
20-Day Relative Strength | 40.82% | 57.37% | 40.44% | ||
Weighted Alpha | -13.53 | -0.78 | -5.34 | ||
Today's Opinion | 100% Sell | 100% Buy | 100% Sell | ||
Previous Opinion | 100% Sell | 96% Buy | 100% Sell | ||
Last Month's Opinion | 56% Sell | 56% Buy | 72% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -5.27% since 03/21/25 | +4.25% since 03/21/25 | -2.46% since 03/21/25 | ||
Low | 49.79 on 03/28/25 | 16.72 on 03/24/25 | 129.97 on 03/28/25 | ||
High | 54.36 on 03/24/25 | 18.03 on 03/28/25 | 135.67 on 03/24/25 | ||
1-Month | |||||
%Chg | -8.89% since 02/28/25 | +7.82% since 02/28/25 | -4.92% since 02/28/25 | ||
Low | 49.79 on 03/28/25 | 16.35 on 03/07/25 | 129.97 on 03/28/25 | ||
High | 55.56 on 03/07/25 | 18.03 on 03/28/25 | 138.29 on 03/07/25 | ||
3-Month | |||||
%Chg | -3.32% since 12/27/24 | +0.39% since 12/27/24 | -2.42% since 12/27/24 | ||
Low | 48.58 on 01/13/25 | 15.55 on 02/06/25 | 129.97 on 03/28/25 | ||
High | 58.94 on 02/06/25 | 18.90 on 01/13/25 | 142.80 on 02/06/25 | ||
6-Month | |||||
%Chg | -20.70% since 09/27/24 | +17.82% since 09/27/24 | -10.08% since 09/27/24 | ||
Low | 48.58 on 01/13/25 | 14.10 on 11/11/24 | 129.61 on 12/19/24 | ||
High | 68.00 on 11/11/24 | 18.95 on 12/19/24 | 150.04 on 11/11/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 59,130 | 3,584 | 6,156,202 | ||
Shares Outstanding, K | 1,180 | 200 | 47,250 | ||
Annual Sales | 0 | 0 | 0 | ||
Annual Net Income | 0 | 0 | 0 | ||
Last Quarter Sales | N/A | N/A | N/A | ||
Last Quarter Net Income | N/A | N/A | N/A | ||
60-Month Beta | 1.63 | -1.41 | 0.84 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | N/A | N/A | ||
Latest Earnings Date | 06/27/14 | N/A | N/A | ||
Most Recent Dividend | 0.131 on 03/26/25 | 0.133 on 03/26/25 | 0.121 on 03/18/25 | ||
Next Ex-Dividends Date | 03/26/25 | 03/26/25 | 03/18/25 | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 15.68 |